Postherpetic Neuralgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. A clear history of herpes zoster (HZ), with pain persisting for >= 1 month after the skin lesions have healed; 2. Age >= 40 years and = 4 on the Visual Analogue Scale (VAS); 4. The patient and their family members were informed and provided consent, agreed to receive the treatment regimen of this study, and signed the treatment informed consent form
Exclusion criteria
Exclusion criteria: 1. Patients with severe cardiovascular or cerebrovascular diseases, or insufficiency of the lungs, liver, or kidneys; 2. Patients with severe psychiatric or psychological disorders; 3. Patients with coagulation dysfunction; 4. Patients with metallic implants, cardiac pacemakers, or defibrillators; 5. Patients with infection at the puncture site; 6. Patients with needle phobia or allergy to the therapeutic drugs; 7. Patients with a history of malignant tumors; 8. Pregnant or lactating women; 9. Patients with immunodeficiency or those on long-term immunosuppressive therapy; 10. Patients with poor compliance, unwillingness to follow medical advice, or refusal to attend follow-up visits
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment Effective Rate;Pittsburgh sleep quality index,PSQI;self-rating anxiety scale, SAS;CD4+, CD8 +, CD4 +/CD8+;Analgesic Consumption;Adverse reactions;self-rating depression scale,SDS; | — |
Countries
China
Contacts
The Affiliated Hospital of Putian University